Re: [177Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p):

Elio Mazzone1, Sachin Perera2, Abhijeet L Neti3

  • 1Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Gianfranco Soldera Prostate Cancer Laboratory, Division of Oncology/Unit of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

European Urology
|July 20, 2024
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos